Disease Info Card

Hyperlipoproteinemia Type Iv

Information about Hyperlipoproteinemia Type Iv: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hyperlipoproteinemia Type Iv

Most recent studies have shown that Hyperlipoproteinemia Type Iv shares some biological mechanisms with arteriosclerosis, atherosclerosis, combined-hyperlipidaemia, coronary-heart-disease, diabetes-mellitus, diabetes-mellitus-non-insulin-dependent, dyslipoproteinemia, heart-diseases, hypercholesterolemia, hypercholesterolemia-familial, hyperlipidemia, hyperlipidemia-familial-combined, hyperlipoproteinemia-type-i, hyperlipoproteinemia-type-iib, hyperlipoproteinemia-type-iii, hyperlipoproteinemia-type-v, hyperlipoproteinemias, hypertensive-disease, obesity, pancreatitis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hyperlipoproteinemia Type Iv, and have been seen in publications frequently: Blood Circulation, Blood Coagulation, Cell Adhesion, Cholesterol Esterification, Coagulation, Excretion, Fermentation, Fibrinolysis, Flocculation, Gallstone Formation, Glucagon Secretion, Hemostasis, Insulin Secretion, Intestinal Absorption, Lipid Transport, Pathogenesis, Platelet Activation, Platelet Aggregation, Secretion, Transport

Quite a number of genes have been found to play important roles in Hyperlipoproteinemia Type Iv, such as APOA1, APOA2, APOB, APOC2, APOC3, APOE, CYP3A4, GZMB, HAP1, INS, LCP1, LDLR, LIPC, LPA, LPL, SKIV2L, TG. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.